2-3 toe syndactyly
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Abnormal aortic morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal carotid artery morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal localization of kidney
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of aortic valve
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of chromosome stability
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of femur morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the corticospinal tract
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the fallopian tube
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the hypothalamus-pituitary axis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the liver
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the outer ear
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the preputium
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absent testes
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acute leukemia
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
RAD51 gene plays an important role in the pathogenesis of squamous cell carcinoma of the head and neck (SCCHN), colorectal cancer, ovarian cancer and acute leukaemia.
|
24457040 |
2014 |
Acute monocytic leukemia
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Adenocarcinoma
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Rad51 expression in adenocarcinoma was significantly higher than normal colonic tissue (p < 0.05).
|
28099437 |
2017 |
Adenocarcinoma
|
0.030 |
Biomarker
|
group |
BEFREE |
The positive rates of RAD51 were 70.2% and 65.4% in high- and low-grade serous adenocarcinomas, respectively (P < 0.05 vs. the control specimens; low- vs. high-grade: P > 0.05).
|
28139510 |
2017 |
Adenocarcinoma
|
0.030 |
Biomarker
|
group |
LHGDN |
Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen.
|
11935313 |
2002 |
Adenocarcinoma of lung (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report.
|
29290255 |
2018 |
Adenocarcinoma of pancreas
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Strikingly, over-expression of wild-type Rad51 was also found in 66% of human pancreatic adenocarcinoma tissue specimens.
|
10851081 |
2000 |
Adenocarcinoma of pancreas
|
0.020 |
Biomarker
|
disease |
BEFREE |
This observation identifies Rad51 as a tumour-associated antigen in pancreatic adenocarcinoma.
|
11935313 |
2002 |
Adenoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
RAD51 mRNA expression was investigated by reverse transcription-polymerase chain reaction (RT-PCR), and sequence analysis of the entire coding region of the RAD51 cDNA was performed in all nine adenomas.
|
10583305 |
1999 |
Adult Fibrosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In order to study the effects of acute HsRad51 ectopic overexpression on cell proliferation, cell cycle progression, and apoptosis, we generated clones of the human fibrosarcoma cell line HT1080 carrying a HsRad51 transgene under a repressible promoter.
|
11461118 |
2001 |
Adult Glioblastoma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
|
28376211 |
2017 |